NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

SNWV

Sanuwave Health Inc

May 16 • 04:00PM ET

32.31

Dollar change +1.00
Percentage change 3.19	%

Healthcare • Medical Devices • USA • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.87	Insider Own	3.82%	Shs Outstand	8.55M	Perf Week	7.34%
Market Cap	276.43M	Forward P/E	-	EPS next Y	-	Insider Trans	1.35%	Shs Float	8.03M	Perf Month	10.54%
Income	-32.52M	PEG	-	EPS next Q	-	Inst Own	39.73%	Short Float	0.17%	Perf Quarter	20.79%
Sales	36.19M	P/S	7.64	EPS this Y	-	Inst Trans	1.16%	Short Ratio	0.32	Perf Half Y	44.24%
Book/sh	-2.02	P/B	-	EPS next Y	-	ROA	-120.05%	Short Interest	0.01M	Perf Year	291.64%
Cash/sh	0.99	P/C	32.52	EPS next 5Y	-	ROE	-	52W Range	5.18 - 39.50	Perf YTD	40.48%
Dividend Est.	-	P/FCF	-	EPS past 5Y	18.26%	ROI	-	52W High	-18.20%	Beta	1.26
Dividend TTM	-	Quick Ratio	0.28	Sales past 5Y	125.11%	Gross Margin	74.42%	52W Low	524.35%	ATR (14)	2.41
Dividend Ex-Date	-	Current Ratio	0.40	EPS Y/Y TTM	34.99%	Oper. Margin	20.59%	RSI (14)	54.73	Volatility	9.69% 7.48%
Employees	46	Debt/Eq	-	Sales Y/Y TTM	61.50%	Profit Margin	-89.86%	Recom	-	Target Price	0.75
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	54.60%	Payout	-	Rel Volume	0.69	Prev Close	31.31
Sales Surprise	-62.18%	EPS Surprise	0.00%	Sales Q/Q	61.46%	Earnings	May 09 BMO	Avg Volume	42.16K	Price	32.31
SMA20	7.70%	SMA50	3.59%	SMA200	53.47%	Trades		Volume	28,978	Change	3.19%

May-09-25 06:00AM	Sanuwave Announces Q1 FY2025 Financial Results (GlobeNewswire)
May-05-25 05:00PM	Sanuwave Will Host a Conference Call on May 9, 2025 at 8:30 AM (ET) to Present Q1 2025 Financial Results (GlobeNewswire)
Apr-30-25 05:10AM	Deep Sail Capital Partner Q1 2025 Investor Letter (Seeking Alpha)
Apr-08-25 08:30AM	SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025) (GlobeNewswire)
Mar-21-25 10:55AM	SANUWAVE Health, Inc. (SNWV) Q4 2024 Earnings Call Transcript (SeekingAlpha) +17.53%
06:00AM	Loading…
06:00AM	SANUWAVE Announces Record Quarterly Revenues: Q4 FY2024 Financial Results (GlobeNewswire)
Mar-17-25 08:00AM	SANUWAVE Will Host a Conference Call on March 21, 2025 at 8:30 AM (ET) to Present Q4 and Full Year 2024 Financial Results (Business Wire) +10.43%
Mar-04-25 04:06PM	Sanuwave Health to Uplist to the Nasdaq Global Market (GlobeNewswire)
Feb-19-25 09:04AM	SANUWAVE Health to Participate in 37th Annual Roth Conference (GlobeNewswire)
Jan-13-25 07:35AM	SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter 2024 (Ended December 31, 2024) (NewMediaWire) +6.67%
07:30AM	SANUWAVE Health Appoints Industry Veteran Timothy Wern as Executive Vice President of Sales (NewMediaWire)

SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Cioanta Iulian	Chief Sci. and Tech. Officer	May 15 '25	Option Exercise	15.70	3,639	57,131	3,680	May 16 04:48 PM
Cioanta Iulian	Chief Sci. and Tech. Officer	May 15 '25	Sale	31.60	3,639	114,992	41	May 16 04:48 PM
Opaleye Management Inc.	10% Owner	Apr 29 '25	Buy	25.49	7,998	203,875	965,000	Apr 30 07:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SNWV

Sanuwave Health Inc

Upgrade your FINVIZ experience